Further to DrugAlert volume 917, HPS Pharmacies wishes to advise that some morphine oral solutions available under Section 19A of the Therapeutic Goods Act 1989 are now subsidised on the Pharmaceutical Benefits Scheme (PBS)….
Read more
Hormone receptor-positive and HER2 receptor-negative (HR+/HER2-) breast cancer can be treated with CDK4/6 inhibitors. When cyclin-dependent kinase (CDK) cellular biology becomes dysregulated, cell proliferation occurs, and this has led to the discovery of three…
Read more
HPS Pharmacies wish to advise that Alphapharm is currently experiencing a supply interruption for trimethoprim tablets as follows: Trimethoprim Viatris Trimethoprim 300 mg tablet ARTG 338350 Normal supplies of Trimethoprim Viatris tablets are expected…
Read more
Further to DrugAlert vol 875, HPS Pharmacies wish to advise that Pfizer is continuing to experience a supply interruption for Heparin as follows: Heparin Sodium Heparin sodium 5000IU/5mL ARTG 49232 The supply interruption for…
Read more
HPS Pharmacies wish to advise that Boehringer Ingelheim intends to discontinue Metalyse® 40mg as follows: Metalyse® Powder for Injection Tenecteplase (rch) 40mg ARTG 75012 The 40mg presentation of Metalyse® will be deleted in September…
Read more
The Pharmaceutical Benefits Scheme (PBS) listing for dapagliflozin has recently been expanded. It is now subsidised for the treatment of heart failure independent of left ventricular ejection fraction (LVEF). When used for the management…
Read more